SU1340591A3 - Способ получени производных 2-тиацефемов - Google Patents

Способ получени производных 2-тиацефемов Download PDF

Info

Publication number
SU1340591A3
SU1340591A3 SU843792605A SU3792605A SU1340591A3 SU 1340591 A3 SU1340591 A3 SU 1340591A3 SU 843792605 A SU843792605 A SU 843792605A SU 3792605 A SU3792605 A SU 3792605A SU 1340591 A3 SU1340591 A3 SU 1340591A3
Authority
SU
USSR - Soviet Union
Prior art keywords
organic solvent
tert
inert organic
chj
formula
Prior art date
Application number
SU843792605A
Other languages
English (en)
Russian (ru)
Inventor
Алпеджиани Марко
Бедески Анжело
Фоглио Маурицио
Франчески Джованни
Перроне Этторе
Original Assignee
Фармиталия Карло Эрба С.П.А. (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармиталия Карло Эрба С.П.А. (Фирма) filed Critical Фармиталия Карло Эрба С.П.А. (Фирма)
Application granted granted Critical
Publication of SU1340591A3 publication Critical patent/SU1340591A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
SU843792605A 1982-12-08 1984-09-26 Способ получени производных 2-тиацефемов SU1340591A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8235058 1982-12-08

Publications (1)

Publication Number Publication Date
SU1340591A3 true SU1340591A3 (ru) 1987-09-23

Family

ID=10534839

Family Applications (1)

Application Number Title Priority Date Filing Date
SU843792605A SU1340591A3 (ru) 1982-12-08 1984-09-26 Способ получени производных 2-тиацефемов

Country Status (4)

Country Link
JP (1) JPS59112989A (enExample)
BE (1) BE898382A (enExample)
SU (1) SU1340591A3 (enExample)
ZA (1) ZA839104B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2125056C1 (ru) * 1993-06-15 1999-01-20 Бристоль-Мейерз Сквибб Компани Соединения, содержащие конденсированное бициклическое ядро, промежуточные соединения, способы их получения и фармацевтическая композиция для ингибирования превращения фермента ангиотензина и нейтральной эндопептидазы

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663451A (en) * 1985-05-09 1987-05-05 Farmitalia Carlo Erba S.P.A. Process for the synthesis of penems and penams
JP5300713B2 (ja) * 2007-03-09 2013-09-25 大塚化学株式会社 ６−ヒドロキシエチルペナム化合物の製造方法
WO2010095617A1 (ja) * 2009-02-19 2010-08-26 大塚化学株式会社 ４－クロロアゼチジノン化合物の製造方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Выложенна за вка DE №2619458, кл. С 07 D 513/04, 1976. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2125056C1 (ru) * 1993-06-15 1999-01-20 Бристоль-Мейерз Сквибб Компани Соединения, содержащие конденсированное бициклическое ядро, промежуточные соединения, способы их получения и фармацевтическая композиция для ингибирования превращения фермента ангиотензина и нейтральной эндопептидазы

Also Published As

Publication number Publication date
BE898382A (fr) 1984-03-30
JPS59112989A (ja) 1984-06-29
JPH0225914B2 (enExample) 1990-06-06
ZA839104B (en) 1984-07-25

Similar Documents

Publication Publication Date Title
US5300638A (en) Asymmetric synthesis of taxol side chain
DK165686B (da) Fremgangsmaade til fremstilling af (3s)-3,4-trans-disubstituerede azetidinoner
US5703234A (en) Heterocyclic alkanamide
FI83521B (fi) Foerfarande foer framstaellning av penemer.
US4734512A (en) Intermediates for the production of podophyllotoxin and related compounds and processes for the preparation and use thereof
Gordon et al. Sulfenyl transfer rearrangement of sulfenimines (thiooximes). A novel synthesis of 7. alpha.-methoxycephalosporins and 6. alpha.-methoxypenicillins
SU1340591A3 (ru) Способ получени производных 2-тиацефемов
SU965357A3 (ru) Способ получени 3-галоидметилцефемов
US4713450A (en) 2-thiacephems and (5R) penems derivatives
FR2504927A1 (fr) Derives de la thiazolinoazetidinone, procedes pour leurs preparations et leur utilisation dans la preparation de cephalosporines
US4704385A (en) 3-formamido azetidinone antibacterial agents, their preparation and use
US5106996A (en) Process for the preparation of podophyllotoxin
US4675396A (en) 7-Oxo-4-thia-1-azabicyclo(3,2,0)heptane derivatives
US4057540A (en) 4-Chloroazetidinone-1-(2',3'-dichloroisopropyl) acetates and process for preparing same
PL145176B1 (en) Process for preparing derivatives of penemo-2-carboxylic-3-acid
KR100899325B1 (ko) 1-옥사세팔로스포린-7α-메톡시-3-클로로메틸 유도체의제조 방법
PL163376B1 (pl) S p osób w y tw a r z a n ia p o ch o d n y ch p e n e m u PL PL PL
JP3118143B2 (ja) アゼチジノン化合物の新規な製法およびその新規原料化合物
US4438265A (en) Esters of 7-sulfenyliminocephem-4-carboxylic acids
JPS609516B2 (ja) セフエム骨格の環化製法
CA1254891A (en) 2-thiacephems
GB2166441A (en) Preparation of 2-thiacephems
GB2131432A (en) Preparation of (5R)-penem derivatives
JPH039115B2 (enExample)
IE56677B1 (en) Preparation of 2-thiacephems